MedicineChemistryMaterials Science

A. Gabizon, H. Shmeeda, S. Zalipsky

2006.1.1JOURNAL OF LIPOSOME RESEARCH

DOI: 10.1080/08982100600848769

tlooto Summary

The pros and cons of the liposome platform in cancer targeting are discussed vis-à-vis nontargeted drugs, using as an example aliposome drug delivery system targeted to the folate receptor.

Abstract

Abstract is not available.

Citation format

GABIZON, A.; SHMEEDA, H.; ZALIPSKY, S. Pros and cons of the liposome platform in cancer drug targeting. JOURNAL OF LIPOSOME RESEARCH, 2006, 16: 175–183.